Patient-oriented life science organizations aiming to improve customer and patient experiences, should develop consistent end-to-end CX-PX interactions across divisions from clinical into commercial.

Life science and healthcare sectors are significantly engaging patients in development and commercial activities. Despite these positive evolutions, patients continue to question what's in for them.

Since a number of years, management of the customer experience (CX) is a hot topic. According to Fortune Business Insights, the global market size for CX technology is estimated to reach 32 billion USD by 2029 with an annual growth rate of 16%.